Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 15696763 | HLA-DRB1*15 | retinitis | NA | valganciclovir | NA | unclassified | |
| among the 80 hla types tested, hla-bw4 (or 11.68, 95% ci 1.29-105.82) and hla-drb115 (or 9.34, 95% ci 1.14-76.41) were significant predictors of cmv retinitis, whereas hla-cw7 was protective against cmv retinitis (or 0.09, 95% ci 0.01-0.67).interpretationwe have identified laboratory variables that elevate (or decrease) the risk of cmv retinitis. | |||||||
| 15696763 | HLA-C*07 | retinitis | NA | valganciclovir | NA | unclassified | |
| among the 80 hla types tested, hla-bw4 (or 11.68, 95% ci 1.29-105.82) and hla-drb115 (or 9.34, 95% ci 1.14-76.41) were significant predictors of cmv retinitis, whereas hla-cw7 was protective against cmv retinitis (or 0.09, 95% ci 0.01-0.67).interpretationwe have identified laboratory variables that elevate (or decrease) the risk of cmv retinitis. | |||||||
| 15696763 | HLA-B4 (BROAD ANTIGEN) | retinitis | NA | valganciclovir | NA | unclassified | |
| among the 80 hla types tested, hla-bw4 (or 11.68, 95% ci 1.29-105.82) and hla-drb115 (or 9.34, 95% ci 1.14-76.41) were significant predictors of cmv retinitis, whereas hla-cw7 was protective against cmv retinitis (or 0.09, 95% ci 0.01-0.67).interpretationwe have identified laboratory variables that elevate (or decrease) the risk of cmv retinitis. | |||||||
| 7720110 | HLA (HLA) | lung adenocarcinoma | NA | NA | NA | unclassified | |
| polymerase chain reaction (pcr), sequencing technique of ds dna cycle and sequencing system were used to detect the gene mutation of n-ras as well as the exon 5 and 7 of p53 gene in hla and ltep-a2 cell lines of human lung adenocarcinoma. | |||||||
| 21822689 | HLA (HLA) | lung adenocarcinoma | NA | NA | NA | only_studied | |
| to evaluate the mdr's effect on the rdr, screen mdr- and rdr-related proteins in human lung adenocarcinoma (hla) cells and tissues a549, and a549/ddp cells after irradiation were analyzed by colony-forming assay and flow cytometry. | |||||||
| 24503571 | HLA (HLA) | lung adenocarcinoma | NA | NA | NA | unclassified | |
| wisp1, ramp1, mybl2 and gata2 could be potential targets of treatment for lung adenocarcinoma and the fusion of hla family genes might have important roles in lung adenocarcinoma. | |||||||
| 27501781 | HLA-CLASS II (HLA CLASS II) | NA | Japanese | rs2179920 | rs2495239 | unclassified | |
| NA | |||||||
| 27501781 | HLA-CLASS II (HLA CLASS II) | NA | Japanese | rs2179920 | rs2495239 | unclassified | |
| NA | |||||||
| 29555781 | HLA-A*02 | lung adenocarcinoma | NA | NA | NA | unclassified | |
| an isolated tcr ab restricted by hla-a*02:01/ct37 peptide redirecting cd8+ t cells to kill and secrete ifn-g in response to lung adenocarcinoma cell lines. | |||||||
| 29642771 | HLA-DR (HLA-DR) | lung adenocarcinoma | NA | NA | NA | unclassified | |
| restoration of peripheral intermediate and classical monocytes expressing hla-dr in patients with lung adenocarcinoma after platinum-based chemotherapy. | |||||||
Copyright 2024